Protocolo clínico e diretrizes terapêuticas para uso de hidroxiureia na doença falciforme

Cançado, Rodolfo D; Lobo, Clarisse; Angulo, Ivan L; Araújo, Paulo I. C; Jesus, Joice A.
Rev. bras. hematol. hemoter ; 31(5): 361-366, 2009.
Artículo en Portugués | LILACS | ID: lil-533598

Documentos relacionados

  1. Systemic medications for sickle cell disease and potential applications for sickle cell retinopathy.
  2. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment.
  3. HbSC disease: A time for progress.
  4. Neurocognitive functioning in preschool children with sickle cell disease.
  5. Characterising the prevalence of overweight and obese status among adults with sickle cell disease.
  6. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
  7. Natural history of blood pressure in sickle cell disease pregnancy.
  8. Mitochondria retention in mature RBCs from haemoglobin SC patients.
  9. Most adults with severe HbSC disease are not treated with hydroxyurea.
  10. Sickle Cell Hemoglobin C Disease Patient Undergoing Coronary Artery Bypass Grafting with Complete Exchange Blood Transfusion during Cardiopulmonary Bypass.